About   Help   FAQ
Phenotype Image Detail
Image
Caption Yolk sac histology. (A) On day E8.5, Haematoxylin and Eosin (H&E) staining and alpha-SMA immunohistochemistry show comparable integrity, erythrocyte filling, alpha-SMA staining of the mesodermal layer of F3tm1Fct/F3tm1Fct (asTF) and wild-type (wt) yolk sacs. (B) On day E9.5, erythrocyte content, wall thickness, and number of alpha-SMA expressing cells are reduced in homozygous mutant yolk sacs. Mutant embryos are found at different stages of growth retardation and wasting. (C) On day E10.5, depletion of erythrocytes, reduced number of alpha-SMA+ cells, thinning and detachment of mesodermal from endodermal layer in homozygous mutant yolk sacs. No intact blood filled vessels can be detected anymore in homozygous mutant yolk sac en face preparations. (D) Quantification of erythrocyte and alpha-SMA+ cell number in E8.5-E10.5 yolk sacs of homozygous mutant and wt embryos ***p<0.001, **p<0.01.
Copyright This image is from Sluka SH, PLoS One 2014;9(5):e97793, and is displayed under the terms of the Creative Commons Attribution 4.0 International License. J:216519
Associated
Alleles
Symbol Name
F3tm1Fct coagulation factor III; targeted mutation 1, Felix C Tanner
Associated
Genotypes
Allelic Composition Genetic Background
F3tm1Fct/F3tm1Fct involves: 129P2/OlaHsd * C57BL/6J

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory